Cellid Co Ltd (299660)

Currency in KRW
1,071
-65(-5.72%)
Closed·
Trading near 52-week Low
299660 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,0711,147
52 wk Range
1,0714,760
Key Statistics
Bid/Ask
1,071.00 / 1,075.00
Prev. Close
1,071
Open
1,136
Day's Range
1,071-1,147
52 wk Range
1,071-4,760
Volume
213.28K
Average Volume (3m)
948.09K
1-Year Change
-73.9416%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
299660 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
01-03-2025
EPS / Forecast
-169.42 / --
Revenue / Forecast
1.88B / --
EPS Revisions
Last 90 days

299660 Income Statement

Compare 299660 to Peers and Sector

Metrics to compare
299660
Peers
Sector
Relationship
P/E Ratio
0.0x−11.9x−0.4x
PEG Ratio
0.00−0.040.00
Price/Book
0.0x1.6x2.6x
Price / LTM Sales
0.0x5.7x3.0x
Upside (Analyst Target)
0.0%27.4%53.2%
Fair Value Upside
Unlock33.0%9.0%Unlock

Cellid, Co., Ltd. develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and sex organ cancer with human papilloma virus infection; BVAC-B for stomach, breast, and ovarian cancer with HER-2/neu antigen; and BVAC-P for prostate cancer, renal cell cancer, and glioblastoma with prostate acid phosphatase (PAP) and prostate-specific membrane (PSMA) antigens. The company is also developing BVAC-M for cancers, such as melanoma with GP100/MAGE-A3 antigens; BVAC-Neo. Cellid, Co., Ltd. was founded in 2006 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
31.43K0.11%35.70M
Other Institutional Investors
300.000.00%340.80K
Public Companies & Retail Investors
29.47M99.89%33.48B
Total
29.5M100.00%33.51B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dimensional Fund Advisors LP0.11%31,42935,703
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.06%17,34619,705

FAQ

What Is the Cellid (299660) Share Price Today?

The Cellid share price today is 1,071.

What is the current Cellid (299660) share price and day range?

As of 20-07-2026, the Cellid share price is 1,071, with a previous close of 1,071. The share price has ranged from 1,071 to 1,147 today, while the 52-week range spans from 1,071 to 4,760.

What Is the Cellid Market Cap?

As of today, Cellid market cap is 31.6B.

From a Technical Analysis Perspective, Is 299660 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Cellid Trade On?

Cellid is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Cellid?

The stock symbol for Cellid is "299660."

How Many Times Has Cellid Stock Split?

Cellid has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.